Saturday, 29 October 2011

Uncertainty, evidence and irrecoverable costs

"This research was commissioned to inform when NICE should approve health technologies only in research (OIR) or with research (AWR)."


Uncertainty, evidence and irrecoverable costs: Informing approval, pricing and research decisions for health technologies
K Claxton, S Palmer, L Longworth, L Bojke, S Griffin, C McKenna, M Soares, E Spackman, J Youn
Centre for Health Economics
October 2011

Read more here.

No comments:

Post a comment